DrugPatentWatch Database Preview
Insulin lispro protamine recombinant; insulin lispro recombinant - Biologic Drug Details
Email this page to a colleague
» See Plans and PricingSummary for insulin lispro protamine recombinant; insulin lispro recombinant
Recent Clinical Trials for insulin lispro protamine recombinant; insulin lispro recombinant
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Universidad de Guanajuato | Phase 4 |
| Medical University of Graz | Phase 1 |
| Eli Lilly and Company | Phase 3 |
See all insulin lispro protamine recombinant; insulin lispro recombinant clinical trials
Patent Text Search: US Patents for insulin lispro protamine recombinant; insulin lispro recombinant
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | HUMALOG MIX 75/25 | insulin lispro protamine recombinant; insulin lispro recombinant | INJECTABLE;INJECTION | 021017 | 001 | 1999-12-22 | Start Trial | INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY (Mumbai, IN) | 2036-02-19 | DISCN | search | |
| Lilly | HUMALOG MIX 75/25 KWIKPEN | insulin lispro protamine recombinant; insulin lispro recombinant | INJECTABLE;INJECTION | 021017 | 002 | 1999-12-22 | Start Trial | INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY (Mumbai, IN) | 2036-02-19 | DISCN | search | |
| Lilly | HUMALOG MIX 75/25 PEN | insulin lispro protamine recombinant; insulin lispro recombinant | INJECTABLE;INJECTION | 021017 | 003 | 1999-12-22 | Start Trial | INDIAN INSTITUTE OF TECHNOLOGY, BOMBAY (Mumbai, IN) | 2036-02-19 | DISCN | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for insulin lispro protamine recombinant; insulin lispro recombinant
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2017141262 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for insulin lispro protamine recombinant; insulin lispro recombinant
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0035 | France | Start Trial | PRODUCT NAME: INSULINE DEGLUDEC; REGISTRATION NO/DATE: EU/1/12/807/001 20130121 |
| 00019 | Netherlands | Start Trial | PRODUCT NAME: INSULINE GLARGINE,DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH GESCHIKT ZOUT; REGISTRATION NO/DATE: EU/1/00/134/001 - 007 20000609 |
| C0044 | Belgium | Start Trial | PRODUCT NAME: INSULIN-ASPART; NAT. REGISTRATION NO/DATE: EU/1/99/119/001 19990907; FIRST REGISTRATION: CH 55045 01 19990615 |
| /2000 | Austria | Start Trial | PRODUCT NAME: LANTUS - INSULIN GLARGIN; REGISTRATION NO/DATE: EU/1/00/134/001 - EU/1/00/134/007 20000609 |
| 01730022 | Spain | Start Trial | PRODUCT NAME: SULIQUA-INSULINA GLARGINA/ LIXISENATIDA; NATIONAL AUTHORISATION NUMBER: EU/1/16/1157; DATE OF AUTHORISATION: 20170111; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/16/1157; DATE OF FIRST AUTHORISATION IN EEA: 20170111 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
